CenterWatch

Clinical Trial Details

Overview

Research Study Summary

Fibromyalgia

Purpose

Suffering from aches, pain and fatigue from fibromyalgia?

If you’re suffering from aches, pain and fatigue from fibromyalgia even though you’re taking the medication Cymbalta®, you may qualify for a medical research study currently being conducted by Meridien Research. This 13 week study will test the effects of the FDA approved medication milnacipran (Savella®) in patients who are not getting relief from their current Cymbalta® regime. Participants may receive study related medication and study related medical care. Medical insurance is not necessary. Compensation for time and travel may be available.

Call Meridien Research today at 727-347-8839 for more information.

To Learn more

CW ID:164952
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Duration
13 Weeks
Facility Type
N/A

Contact

Meridien Research
4751 66th Street North
St. Petersburg, FL 33709
Phone: 727-347-8839

View Map

Research Center Information: Meridien Research

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.